摘要
目的观察应用人工肝支持系统(ALSS)治疗各种药物所致的肝损伤的临床疗效。方法治疗组32例药物性肝损伤患者在内科综合治疗基础上同时加用ALSS治疗。对照组30例仅给予内科综合治疗。结果治疗后肝性脑病的改善,治疗前、后血清胆红素分别为(614±217)μmol/L和(224±92)μmol/ L,t=3.21,P<0.05;凝血酶原时间活动度分别为(31±6)%和(78±20)%,t=2.43,P<0.05,差异有统计学意义。治疗组治愈好转率为90.6%,平均住院治疗天数为47d,对照组治愈好转率为43.3%,平均住院天数为72 d,t=2.05,P<0.05,两组比较差异有统计学意义。结论在内科综合治疗基础上给予ALSS 对药物性肝损伤具有明显疗效。
Objective To study the effectiveness of an artificial liver support system. Methods Thirty-two patients with medicamentous liver insufficiency were treated with an artificial liver support system in addition to the routine medicinal therapy. Thirty patients treated with routine medicinal therapy only served as controls. Results The clinical symptoms （e.g. hepatic encephalopathy） and the laboratory indices （serum total bilirubin and prothrombin time） of the treatment group patients were obviously improved compared with those of the control group patients （P 〈0.05）. The cure rate and hospitalization days were 90.6% （26/32） and 47 days respectively in the treatment group, and 43.3% （13/30） and 72 days in the control group （P 〈0.05）. Conclusion Using an artificial liver support system combined with routine medicinal therapy is more effective than using medication alone.
出处
《中华肝脏病杂志》
CAS
CSCD
北大核心
2005年第11期836-838,共3页
Chinese Journal of Hepatology
